The global spine biologics market is forecasted to grow at a 4.4 percent compound annual growth rate to exceed $2.6 billion by 2020, according to a Market Research Engine report.
Here are 17 key players in the market:
1. DePuy Spine
2. Precision Spine
3. Medtronic
4. Stryker Corporation
5. Smith & Nephew
6. Orthovita
7. Zimmer Spine
8. K2M
9. Nuvasive
10. Arthrex
11. DMP Spine,
12. Alphatec Spine
13. Orthofix
14. RTI Surgical
15. Wright Medical Technology
16. Cesca Therapeutics
17. Lattice Biologics
More articles on biologics:
Dr. Chad Lavender performs ACL repair with bone marrow: 3 things to know
Stem cell therapy successfully repairs torn meniscus in case study: 4 findings